Company intelligence / Profile preview
奇正藏药
Nyingchi (林芝), Tibet Autonomous Region, Chinaemweb.eastmoney.com ↗
- Ownership
- Private
- Employees
- ~2310
- Development stage
- Commercial
01
Overview
The company has established itself as a leading Tibetan medicine manufacturer with a focus on pain relief products. Their pain relief medicine achieved CNY 499 million in sales, capturing 10% of the market share in 2008, making it the highest-selling external pain relief medicine in the domestic market that year[6]. Recent financial reports show continued growth with revenue of 1,009.83 million yuan in the first half of 2024, a 21.70% increase year-over-year[4].
- Therapeutic areas
- Neurology
- Modalities
- Traditional Tibetan medicineexternal pain relief medicationsoral Tibetan medicines
- Industry
- Biotech
02
Drug pipeline
23 assets22 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on 奇正藏药.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 奇正藏药.